DK460387A - Sammensaetning, der er i stand til at frembringe et immunologisk respons i et pattedyr paa en udvalgt epitop - Google Patents

Sammensaetning, der er i stand til at frembringe et immunologisk respons i et pattedyr paa en udvalgt epitop

Info

Publication number
DK460387A
DK460387A DK460387A DK460387A DK460387A DK 460387 A DK460387 A DK 460387A DK 460387 A DK460387 A DK 460387A DK 460387 A DK460387 A DK 460387A DK 460387 A DK460387 A DK 460387A
Authority
DK
Denmark
Prior art keywords
mammal
generating
composition capable
immunological response
selected epitope
Prior art date
Application number
DK460387A
Other languages
English (en)
Other versions
DK460387D0 (da
DK171602B1 (da
Inventor
Marta Iris Sabara
Patrick John Frenchick
Kerry Frances Mullin-Ready
Original Assignee
Univ Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Saskatchewan filed Critical Univ Saskatchewan
Publication of DK460387D0 publication Critical patent/DK460387D0/da
Publication of DK460387A publication Critical patent/DK460387A/da
Application granted granted Critical
Publication of DK171602B1 publication Critical patent/DK171602B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6075Viral proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/62Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/627Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/12011Reoviridae
    • C12N2720/12311Rotavirus, e.g. rotavirus A
    • C12N2720/12322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK460387A 1986-09-03 1987-09-03 Sammensætning, der er i stand til at frembringe et immunologisk respons i et pattedyr på en udvalgt epitop, vaccinesammensætning som omfatter molekyler, der bærer den givne epitop, og fremgangsmåde til fremstilling af vaccinen DK171602B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90322286A 1986-09-03 1986-09-03
US90322286 1986-09-03

Publications (3)

Publication Number Publication Date
DK460387D0 DK460387D0 (da) 1987-09-03
DK460387A true DK460387A (da) 1988-03-04
DK171602B1 DK171602B1 (da) 1997-02-17

Family

ID=25417135

Family Applications (1)

Application Number Title Priority Date Filing Date
DK460387A DK171602B1 (da) 1986-09-03 1987-09-03 Sammensætning, der er i stand til at frembringe et immunologisk respons i et pattedyr på en udvalgt epitop, vaccinesammensætning som omfatter molekyler, der bærer den givne epitop, og fremgangsmåde til fremstilling af vaccinen

Country Status (10)

Country Link
EP (1) EP0259149B1 (da)
JP (1) JPS63218627A (da)
AT (1) ATE98493T1 (da)
AU (1) AU608769B2 (da)
CA (1) CA1319101C (da)
DE (1) DE3788475T2 (da)
DK (1) DK171602B1 (da)
ES (1) ES2060603T3 (da)
IE (1) IE61417B1 (da)
IL (1) IL83755A (da)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6086880A (en) * 1985-12-26 2000-07-11 The University Of Saskatchewan Rotavirus peptide compositions and methods of use
CA1340530C (en) * 1989-04-28 1999-05-04 Kok Kheong Lee Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics
GB9000143D0 (en) * 1990-01-04 1990-03-07 Natural Environment Res Test kit and method for the diagnosis of bluetongue
US5298244A (en) * 1990-10-25 1994-03-29 University Of Saskatchewan Assembled viral particles and their use in a vaccine to rotaviral disease
US5431899A (en) * 1991-02-04 1995-07-11 University Of Saskatchewan Rotavirus VP6 as a diagnostic and targeting agent
JPH06506667A (ja) * 1991-02-04 1994-07-28 ユニバーシティ オブ サスカチェワン カプセル化したvp6の薬物送達
CA2162557C (en) 1993-05-12 2004-09-28 Amy J. Weiner Conserved motif of hepatitis c virus e2/ns1 region
US5820868A (en) 1993-12-09 1998-10-13 Veterinary Infectious Disease Organization Recombinant protein production in bovine adenovirus expression vector system
US6150137A (en) 1994-05-27 2000-11-21 Ariad Pharmaceuticals, Inc. Immunosuppressant target proteins
US6777217B1 (en) 1996-03-26 2004-08-17 President And Fellows Of Harvard College Histone deacetylases, and uses related thereto
DE19618797C2 (de) * 1996-05-10 2000-03-23 Bertling Wolf Vehikel zum Transport molekularer Substanz
AU750702B2 (en) * 1997-05-01 2002-07-25 Chiron Corporation Use of virus-like particles as adjuvants
ATE377087T1 (de) 1997-06-23 2007-11-15 Univ Saskatchewan Verfahren zur herstellung eines rekombinanten rinderadenovirus-vektors
DE19750354A1 (de) * 1997-11-13 1999-05-27 November Ag Molekulare Medizin Verfahren zur Applikation von Wirkstoffen
US6492343B1 (en) 1998-04-15 2002-12-10 University Of Saskatchewan Porcine adenovirus type 3 genome
DE19829005C2 (de) * 1998-06-29 2000-08-31 November Ag Molekulare Medizin Verfahren zum Transport molekularer Substanz in vorgegebene Bereiche eukaryontischer Zellen
EP1127151A2 (en) 1998-11-02 2001-08-29 University of Saskatchewan Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors
JP2010510960A (ja) 1998-11-30 2010-04-08 サイトス バイオテクノロジー アーゲー 抗原の順序付けられた分子提示、提示の方法、および使用
US6451319B1 (en) 1999-04-09 2002-09-17 Schering-Plough Veterinary Corporation Recombinant and mutant adenoviruses
US6299882B1 (en) 1999-04-09 2001-10-09 Schering Corporation UL54.5 of Marek's disease virus (MDV)
DE19916224C1 (de) 1999-04-10 2000-06-21 November Ag Molekulare Medizin Synthetisches biologisch aktives Molekül
US7396905B1 (en) 1999-05-21 2008-07-08 Mckeon Frank Calcipressins: endogenous inhibitors of calcineurin, uses and reagents related thereto
EP1287162A2 (en) 1999-10-21 2003-03-05 Case Western Reserve University Gene expression profiling of inflammatory bowel disease
US20030129724A1 (en) 2000-03-03 2003-07-10 Grozinger Christina M. Class II human histone deacetylases, and uses related thereto
AU2001252458A1 (en) 2000-05-05 2001-11-20 Martin Bachmann Molecular antigen arrays and vaccines
CA2410665C (en) 2000-05-31 2017-11-07 University Of Saskatchewan Modified bovine adenovirus having altered tropism
US7128911B2 (en) 2001-01-19 2006-10-31 Cytos Biotechnology Ag Antigen arrays for treatment of bone disease
US7094409B2 (en) 2001-01-19 2006-08-22 Cytos Biotechnology Ag Antigen arrays for treatment of allergic eosinophilic diseases
US7320793B2 (en) 2001-01-19 2008-01-22 Cytos Biotechnology Ag Molecular antigen array
US7244853B2 (en) 2001-05-09 2007-07-17 President And Fellows Of Harvard College Dioxanes and uses thereof
US7569217B2 (en) 2001-09-24 2009-08-04 University Of Saskatchewan Porcine adenovirus E1 and E4 regions
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
EP1532167B1 (en) 2002-07-17 2012-01-25 Cytos Biotechnology AG Molecular antigen arrays using a virus like particle derived from the ap205 coat protein
KR101228376B1 (ko) 2002-07-18 2013-01-31 사이토스 바이오테크놀로지 아게 합텐-캐리어 컨쥬게이트 및 그의 용도
JP4644488B2 (ja) 2002-07-19 2011-03-02 サイトス・バイオテクノロジー・アクチェンゲゼルシャフト アミロイドベータ1−6抗原アレイを含むワクチン組成物
AU2003255967A1 (en) 2002-07-19 2004-02-09 University Of Saskatchewan Pav regions for encapsidation and e1 transcriptioonal control
US7264818B2 (en) 2003-06-10 2007-09-04 University Of Saskatchewan BAV packaging regions and E1 transcriptional control regions
EP1784220B1 (en) 2004-08-26 2017-12-20 The University Of Western Ontario Bacterial iron acquisition targets
CA2601706C (en) 2005-03-22 2016-09-20 Dana-Farber Cancer Institute, Inc. Treatment of protein degradation disorders
EP2224008A3 (en) 2005-05-12 2010-12-01 Murdoch University Genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
WO2007059166A2 (en) 2005-11-14 2007-05-24 Weber Georg F Peptide sequence that promotes tumor invasion
CN101400362B (zh) 2006-02-14 2016-10-12 哈佛大学校长及研究员协会 双官能组蛋白去乙酰化酶抑制剂
WO2007130429A2 (en) 2006-05-03 2007-11-15 The President And Fellows Of Harvard College Histone deacetylase and tubulin deacetylase inhibitors
US8992938B2 (en) 2007-08-03 2015-03-31 Matthew Bellgard Genes and proteins of Brachyspira hyodysenteriae and uses thereof
GB0720250D0 (en) 2007-10-17 2007-11-28 Univ Edinburgh Immunogenic compositions containing escherichia coli h7 flagella and methods of use thereof
EP2363407A1 (en) 2008-02-28 2011-09-07 Murdoch University Novel sequences of Brachyspira, immunogenic compositions, methods for preparation and use thereof
EP2271664A4 (en) 2008-03-27 2011-11-23 Prionics Ag NEW SEQUENCES OF BRACHYSPIRA, IMMUNOGENIC COMPOSITION, METHOD OF MANUFACTURE AND APPLICATION THEREOF
AU2009274549B2 (en) 2008-07-23 2014-05-01 Dana-Farber Cancer Institute, Inc. Deacetylase inhibitors and uses thereof
US8716344B2 (en) 2009-08-11 2014-05-06 President And Fellows Of Harvard College Class- and isoform-specific HDAC inhibitors and uses thereof
CN111569056B (zh) * 2020-05-26 2022-09-27 山东信得科技股份有限公司 一种猪轮状病毒疫苗、制备该疫苗的抗原及其编码序列

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0235391B1 (en) * 1985-12-26 1992-06-10 The University of Saskatchewan Peptides corresponding to antigenic and immunogenic determinants of major neutralizing proteins of rotaviruses
US5186933A (en) * 1986-12-30 1993-02-16 Baylor College Of Medicine Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system

Also Published As

Publication number Publication date
IE872353L (en) 1988-03-03
EP0259149A2 (en) 1988-03-09
IE61417B1 (en) 1994-11-02
IL83755A (en) 1993-04-04
EP0259149A3 (en) 1989-05-24
DE3788475D1 (de) 1994-01-27
DK460387D0 (da) 1987-09-03
AU7791887A (en) 1988-03-10
CA1319101C (en) 1993-06-15
ATE98493T1 (de) 1994-01-15
AU608769B2 (en) 1991-04-18
EP0259149B1 (en) 1993-12-15
DK171602B1 (da) 1997-02-17
JPS63218627A (ja) 1988-09-12
IL83755A0 (en) 1988-02-29
ES2060603T3 (es) 1994-12-01
DE3788475T2 (de) 1994-04-07

Similar Documents

Publication Publication Date Title
DK460387A (da) Sammensaetning, der er i stand til at frembringe et immunologisk respons i et pattedyr paa en udvalgt epitop
ATE47155T1 (de) Monoklonaler antikoerper.
JPS5214694A (en) Polytriazine with high molecular weight
JPS5282049A (en) Control system for information alternation of terminal equipment
JPS5214695A (en) Polytriazine with high molecular weight
DK134651B (da) Substrat til bestemmelse af desoxyribonuclease og dettes antistoffer, indeholdende et kompleks af hojmolekyler desoxyribonucleinsyre og et farvestof, samt fremgangsmade til fremstilling af dette substrat
IT1126709B (it) Procedimento di candeggio ottico per substrati costituiti,in parte o in totalita',da poliammidi sintetiche
DK139432B (da) Analogifremgangsmåde til fremstilling af indol(2,3-a)kinolizidinderivater.
CA946537A (en) Modified high molecular weight polyamides with high affinity for acid dyes
ES245420U (es) Recipiente de metal en especial para gas a presion
SU524991A1 (ru) Стенд дл испытани ведущих мостов транспортных средств
SU938063A1 (ru) Стенд дл испытани транспортных средств
SU605975A1 (ru) Междуэтажна крепь
AU534486B2 (en) 4,5,5a,6-tetrahydro-dibenz(cd,f)indoles
Barkin Analysis Symposium: Webern, Orchestra Pieces (1913) Movement I (" Bewegt")
SU592005A2 (ru) Баланснный модул тор
IT7922021A0 (it) Coloranti reattivi antrachinonici.
JPS51140702A (en) Semiconductor laser pickup apparatus
SU608653A2 (ru) Устройство дл выделени полимерных материалов из их растворов
GR3006212T3 (da)
SU658500A1 (ru) Цифровой фазометр
SU596370A1 (ru) Стенд дл ремонта ковшей
JPS5273458A (en) Derrick loading system
JPS51118448A (en) Polarizing prism
JPS5236185A (en) Preparation of novel reactive polymer

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed